Acrivon Therapeutics, Inc.
ACRV· Nasdaq
Acrivon Therapeutics, Inc.
- Last sale
- Sep 28, 2026 · -3.33%
- Market cap
- $86.99M
- 42.85M shares
- Filings
- 344
Price
Sep 28, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $59,990,000 | reported | |
| FY 2024 | 2024-12-31 | $63,992,000 | reported | |
| FY 2023 | 2023-12-31 | $46,024,000 | reported | |
| FY 2022 | 2022-12-31 | $23,949,000 | reported |
Acrivon Therapeutics, Inc. · CIK 1781174 · Engraved from SEC EDGAR
